Published in Mol Cancer Res on May 21, 2014
Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators. Int J Cancer (2016) 0.75
Sex differences in skin carotenoid deposition and acute UVB-induced skin damage in SKH-1 hairless mice after consumption of tangerine tomatoes. Mol Nutr Food Res (2015) 0.75
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma. Oncotarget (2016) 0.75
Cancer-related inflammation. Nature (2008) 34.21
A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med (1999) 4.15
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A (2001) 3.29
Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol (2013) 2.92
Cancer-related inflammation. J Clin Immunol (2012) 1.91
Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res (2005) 1.73
Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity (2007) 1.73
Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res (2007) 1.57
Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog (2003) 1.39
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link. QJM (2010) 1.29
JAB1/CSN5: a new player in cell cycle control and cancer. Cell Div (2010) 1.29
Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res (1999) 1.25
Early events in UV carcinogenesis--DNA damage, target cells and mutant p53 foci. Photochem Photobiol (2008) 1.20
Photoinduced damage to cellular DNA: direct and photosensitized reactions. Photochem Photobiol (2012) 1.19
Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res (2001) 1.19
Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem (2008) 1.16
Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem (2006) 1.14
Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol (2009) 1.13
p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol (2006) 1.13
Control of p53 and NF-κB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cell Signal (2010) 1.11
Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med (2008) 1.08
Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol (2008) 1.05
Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci (2005) 1.01
Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J (2010) 0.99
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC). FASEB J (2008) 0.98
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div (2007) 0.96
Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene (2005) 0.95
Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity. J Biol Chem (2008) 0.95
A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease. FASEB J (2010) 0.93
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. Int J Oncol (2013) 0.92
MIF: a key player in cutaneous biology and wound healing. Exp Dermatol (2011) 0.90
GammaH2AX, an accurate marker that analyzes UV genotoxic effects on human keratinocytes and on human skin. Photochem Photobiol (2010) 0.90
Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis. Anticancer Res (2012) 0.87
Molecular events associated with apoptosis and proliferation induced by ultraviolet-B radiation in the skin of hairless mice. J Dermatol Sci (2003) 0.87
Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Photochem Photobiol (2012) 0.83
Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis. Carcinogenesis (2009) 0.83
The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis. Cancers (Basel) (2010) 0.82
Gastric cancer susceptibility in gastric cancer relatives: attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori. Cytokine (2012) 0.79
Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders. Indian J Dermatol (2013) 0.76